CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Bristol-Myers Squibb Company v. ScieGen Pharmaceuticals, Inc.

1:23-cv-00393

Overview

Case Number 1:23-cv-00393
Filing Date 2023-04-06
Status Litigation filed
Court District Court, D. Delaware
Nature of Suit 830 Patent

Parties

Defendant

ScieGen Pharmaceuticals, Inc.

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

Bristol-Myers Squibb Company

Represented By

0 Attorneys Listed
No attorneys available

Court & Judges

Court

District Court, D. Delaware

Presiding Judge

Gregory B. Williams

Patents Involved

No asserted patent numbers detected in initial docket filings yet.

Docket Entries

COMPLAINT for PATENT INFRINGEMENT filed against ScieGen Pharmaceuticals, Inc. (Filing fee $ 402, receipt number ADEDC-4107837.) - filed by Bristol-Myers Squibb Company and Pfizer Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet) (mkr) (Entered: 04/10/2023)

2023-04-06
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mkr) (Entered: 04/10/2023)

2023-04-06
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 3/4/2023. Date of Expiration of Patent: 2/24/2031.Thirty Month Stay Deadline: 9/4/2025. (mkr) (Entered: 04/10/2023)

2023-04-06
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,326,945 B2. (mkr) (Entered: 04/10/2023)

2023-04-06
1